Instalab
logoInstalab

C1q Antibody IgG

Blood Test
Add evidence when lupus kidney inflammation is suspected.
4.9 (2,937 reviews)
Tested by Quest Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a C1q Antibody IgG test?

This test is most useful if any of these apply to you.

Living With Lupus
If kidney involvement is suspected, this antibody can add context to your urine, kidney function, and other immune tests.
Getting Hives That Leave Bruises
Persistent welts may need evaluation for blood vessel inflammation; this antibody can support the workup.
Being Evaluated for Lupus
If symptoms and other findings suggest lupus kidney involvement, this can provide additional evidence.
Following Up on Lupus Kidney Disease
Repeat testing may add context if this antibody has tracked your disease, alongside urine and kidney function results.

About C1q Antibody IgG

Kidney inflammation can develop in lupus before you notice symptoms. Anti-C1q IgG can add evidence when kidney involvement is suspected, especially when interpreted with urine findings, kidney function, and other immune markers. A positive result can strengthen that suspicion, but a negative result doesn't reliably exclude kidney inflammation.

What the Antibody Targets

Your blood carries a group of proteins called complement, which help defend against infection and clear damaged cells and antibody clusters. C1q recognizes certain targets and starts one branch of this system. Its role in clearing dying cells is relevant to lupus, where problems with this clearance may contribute to ongoing immune activity.

An autoantibody is an antibody directed against part of your own body. This test measures IgG autoantibodies against C1q in serum. Serum is the liquid left after blood clots. The laboratory uses an ELISA assay to detect antibody binding to C1q and reports the result in units specific to that assay.

Experiments in mice suggest these antibodies can worsen kidney inflammation when C1q-containing antibody clusters are already deposited in the kidney's filters. This supports a possible mechanism for the association seen in people. It doesn't establish that every positive result represents antibodies causing kidney damage.

Lupus and Kidney Inflammation

Systemic lupus erythematosus can affect the skin, joints, blood cells, kidneys, and other organs. Lupus nephritis is kidney inflammation caused by lupus. It can damage the kidney's filters, allowing protein or blood into the urine, sometimes while you still feel well.

Studies measuring serum anti-C1q IgG have found it more often in people with active lupus nephritis than in those without kidney involvement. The association is particularly clear in forms with substantial inflammation inside the kidney's filters. Positive anti-C1q together with anti-double-stranded DNA antibodies and low complement C3 and C4 strengthens the evidence for kidney involvement. These findings still need to agree with the urine results and clinical picture.

Some early studies found a negative result strongly reassuring, but larger analyses showed that active lupus nephritis can occur without detectable anti-C1q. How much reassurance a negative result provides depends on how likely kidney inflammation was before testing. New urine abnormalities or declining kidney function remain concerning even when this antibody is negative.

Hives From Inflamed Blood Vessels

Urticarial vasculitis causes hive-like welts through inflammation in small blood vessels of the skin. Individual welts often last longer than a day and may leave bruising or darker marks. They can burn, hurt, or itch. Some people also develop deeper swelling.

When this condition occurs with low complement levels, it's called hypocomplementemic urticarial vasculitis. Anti-C1q antibodies are often present and can support the diagnosis, but some affected people test negative. This form can involve the joints, eyes, lungs, and kidneys, and it can overlap with lupus. Diagnosis depends on the symptoms, complement results, and usually a skin biopsy.

Positive Results in Other Settings

Anti-C1q antibodies also occur in other autoimmune diseases, some chronic infections, and a minority of healthy people. A population study found higher levels in older adults, although the age pattern was different in people with lupus. An isolated positive result doesn't establish an autoimmune disease or show which organ is affected.

This marker has recognized specialist uses, but its assays are less standardized than many routine laboratory tests. Human studies support its association with lupus kidney inflammation. Using the antibody alone to predict an individual flare or decide treatment remains unproven.

When Results Can Be Misleading

  • Different test kits: ELISA kits differ in their preparation of C1q, calibration, and reporting units. The same sample can receive different numbers or classifications with different kits.
  • Nonspecific binding: circulating antibody clusters can bind to C1q used in an assay and resemble anti-C1q antibodies. Assays use conditions designed to reduce this interference, but their performance varies.
  • Disease activity outside the kidneys: anti-C1q can accompany broader lupus activity, so a change doesn't identify the kidneys as the source of inflammation.

Tracking Your Trend

In some longitudinal studies, rising or persistently high anti-C1q levels were associated with later kidney flares. Other studies found that flares weren't preceded by an antibody rise. A trend may add context, especially if this antibody has tracked your disease before, but it cannot reliably tell you when a flare will happen.

What Moves This Biomarker

Evidence-backed interventions that affect your C1q Antibody IgG level

↓ Decrease
Corticosteroid-based treatment for lupus nephritis, including regimens with cyclophosphamide or mycophenolate
Human studies found substantial falls in serum anti-C1q antibodies over months during treatment for lupus nephritis. These regimens treat kidney inflammation, but a falling antibody result alone doesn't prove that kidney inflammation has resolved.
MedicationStrong Evidence

Frequently Asked Questions

C1q Antibody IgG Test

$195
FSA/HSA eligible
No Rx needed
HIPAA compliant